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           T
HE rapid and ongoing spread of antimicrobial-resistant 
bacteria throughout all health care institutions is consid-
ered a critical medical and public health issue ( 1 ). Residents of 
long-term care facilities (LTCF) are one of the main reservoirs 
of antimicrobial-resistant bacteria with reported prevalence 
rates similar to patients in the intensive care unit (  2    –    6  ). Epide-
miological studies and infection control initiatives in LTCF 
have focused predominantly on methicillin-resistant   Staphy-
lococcus aureus   (MRSA) and vancomycin-resistant entero-
cocci (VRE). Recently, it has become apparent that multidrug 
resistance among gram-negative bacteria is becoming an even 
greater problem in these facilities, with more than half of 
LTCF residents harboring multidrug-resistant gram-negative 
bacteria (MDRGN) (  5  ). Infections caused by MDRGN are as-
sociated with higher mortality rates, longer length of hospital 
stays, and greater hospital costs compared with infections 
caused by antimicrobial-susceptible gram-negative bacteria 
(  7  ). Health care costs associated with MDRGN infections are 
even greater than those associated with MRSA infections (  8  ). 
Despite the poor outcomes associated with MDRGN infec-
tions, few studies have focused on these emerging antimicro-
bial-resistant bacteria in the LTCF population and compared 
its relevance to other more frequently studied antimicrobial-
resistant bacteria, including MRSA and VRE. 
  The goal of this study was to provide detailed data on the 
prevalence and temporal trends of MDRGN, MRSA, and 
VRE from one large urban LTCF for a period of 2 years. 
These data are needed to further our understanding of the 
transmission dynamics of antimicrobial-resistant bacteria 
within the LTCF setting and ultimately design effective and 
appropriate infection control strategies aimed at limiting the 
spread of antimicrobial-resistant bacteria, not only in our 
elderly population but also to other patient populations they 
encounter in the acute care and community settings.   
 Methods 
  The study was performed at the Hebrew Rehabilitation 
Center for the Aged, which provides care for an average of 
700 LTC residents and 50 acute rehabilitation residents in 
the metropolitan Boston, Massachusetts, area. Microbiol-
ogy records of all clinical cultures (collected as a part of 
routine medical care), obtained from residents between 
November 2003 and September 2005, were reviewed retro-
spectively. All cultures were processed at a single off-site 
commercial microbiology laboratory. Demographic infor-
mation for the study population was obtained by extracting 
existing data from the Minimum Data Set (MDS). The MDS 
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is a core set of items and includes demographic information 
and clinical indicators used to assess all of the nation’s nurs-
ing home residents who reside in facilities participating in 
the Medicare or Medicaid programs. Data extracted from 
MDS have been widely used and demonstrated to be reli-
able for research purposes (  9  ,  10  ). Demographic data in the 
form of age, gender, and length of stay were obtained in ag-
gregate form via an MDS query using SPSS (SPSS Inc., 
Chicago, IL) for extraction and analysis. The most recent 
full MDS assessment conducted on each resident during the 
study period was used for analysis. 
  Clinical cultures positive for MDRGN, MRSA, and VRE 
were included in the analysis. Antibiotics chosen for inclu-
sion in the deﬁ  nition of multidrug resistance among gram-
negative bacteria included those in which susceptibility 
testing was reported for at least 80% of isolates per study 
year. Criteria for multidrug resistance among gram-negative 
bacteria were deﬁ  ned as resistance or intermediate resistance 
to three or more of the following antimicrobials or antimi-
crobial groups consistent with previously published work 
( 5 , 6 ):  extended-spectrum  penicillins  (ampicillin/sulbactam 
or piperacillin/tazobactam), cephalosporins (cefazolin or 
ceftriaxone), gentamicin, ciproﬂ  oxacin, and trimethoprim-
sulfamethoxazole (TMP/SMX). 
  The prevalence of MDR bacteria, coresistance patterns 
among MDRGN, and temporal trends over time were ana-
lyzed. The study period was divided into four time intervals 
to reduce monthly ﬂ  uctuations. Only one isolate per resi-
dent per month was included for those residents in whom 
multiple MDR bacteria with identical susceptibility patterns 
were recovered from multiple cultures. Temporal trends in 
antimicrobial resistance were analyzed using the chi-
squared test for trend.   p   values  of   < 0.5     were  considered  sta-
tistically signiﬁ   cant. All analyses were performed using 
STATA 10.0 (Stata Corp., College Station, TX). The con-
duct of this study was approved by the institutional review 
board at the study institution.     
 Figure  1 .        Rates  of  Multidrug-Resistant  Gram-Negative  Bacteria  (MDGRN), 
Vancomycin-Resistant Enterococci (VRE), and Methicillin-Resistant   Staphylo-
coccus aureus   (MRSA) Recovered From Clinical Cultures for the Study Period.       
 Results 
  A total of 975 residents resided in the LTCF during the 
study period. The average age for this population was 88.2 
years (standard deviation   ±   7.9) of whom 74.6% were 
women. Caucasians represented 98.5% of the study popula-
tion, with other racial groups, including Native American, 
Black, and Hispanic, accounting for less than 1% each. A 
total of 313 (32.1%) residents died during the study period. 
A total of 3,578 clinical cultures were obtained during the 
study period, of which 3,029 (84.7%) were from urine, 307 
(8.6%) from blood, and 242 (6.8%) from wound specimens. 
Bacterial growth was identiﬁ  ed among 2,032 (56.8%) cul-
tures, of which 1,789 (88%), 224 (11%), and 19 (1.0%) 
were recovered from urine, wound, and blood specimens, 
respectively. Cultures reported as normal ﬂ  ora,  mixed 
growth, or probable contaminant (355 [17.5%]), and repeat 
cultures growing the same organisms with identical suscep-
tibility patterns, taken from a single individual within a 
1-month period (16 [0.007%]), were excluded. The remain-
ing 1,661 isolates are described in the following analysis. 
  A total of 824 (49.6%) isolates were identiﬁ  ed as gram-
negative bacteria, of which 180 (21.8%) met the criteria 
deﬁ  ned in this study for multidrug resistance. Gram-positive 
bacteria were isolated from 837 cultures of which 104 
(12.4%) isolates were identiﬁ  ed as MRSA and 11 (1.3%) 
isolates were identiﬁ  ed as VRE. MRSA was recovered from 
urine (56.7%) and wound (43.3%) cultures. VRE was recov-
ered from urine (90.9%) and wound (9.1%) cultures. Rates 
of VRE, MRSA, and MDRGN during the study period are 
shown in   Figure 1  . For the 6-month intervals during the 
study period, rates of MDRGN were 7.9%, 9.8%, 13.7%, 
and 14.0%. MRSA rates were 3.0%, 2.0%, 10.4%, and 7.8%, 
and rates of VRE were 0.0%, 0.7%, 1.0%, and 1.0%. 
MDRGN were more frequently isolated than MRSA or VRE 
throughout the study period. The prevalence of MRSA and 
MDRGN increased signiﬁ  cantly over time (  p   = 0.001 and 
  p   = 0.02, respectively). MDRGN were recovered from the 
following sites (number of specimens [percent]): urine (169 
[93.9%]), wound (10 [5.6%]), and blood (1 [0.5%]). The 
most common MDRGN species were   Proteus mirabilis   (92 
[51.1%] isolates),   Escherichia coli   (47 [26.1%] isolates), 
and   Providencia stuartii   (19 [10.6%] isolates). Other species 
of MDRGN included   Klebsiella pneumoniae   (8 [4.4%] iso-
lates),   Morganella morganii   (5 [2.8%] isolates),   Klebsiella 
oxytoca   (3 [1.7%] isolates),   Stenotrophomonas maltophilia  
(2 [1.1%] isolates), and   Enterobacter aerogenes   (1 [0.6%] 
isolate). MDRGN isolates were resistant to (percent of iso-
lates) ciproﬂ  oxacin (96.7%), ampicillin/sulbactam (92.1%), 
TMP/SMX (81.5%), gentamicin (79.4%), cefazolin (54.3%) 
ceftriaxone (13.6%), and piperacillin/tazobactam (5.1%). 
Susceptibility testing to ceftazidime, cefepime, and impe-
men was performed on less than 20% of isolates. A total of 
13 different coresistance patterns among MDRGN isolates 
were identiﬁ  ed. Among these, resistance to three, four, and 
ﬁ   ve or more antimicrobials were identiﬁ   ed among 122    O ’ FALLON  ET  AL.  140
(67.8%),   47 (26.1%), and 11 (6.1%) MDRGN isolates, re-
spectively. The most common coresistant pattern was three-
drug resistance to ciproﬂ  oxacin, gentamicin, and TMP/SMX 
present among 79 (43.9%) MDRGN isolates (  Figure 2  ). Co-
resistance patterns among the most common MDRGN spe-
cies,   P. mirabilis ,   E. coli  , and   P. stuartii  , were also analyzed. 
Among   P. mirabilis   isolates, the most common coresistance 
pattern was three-drug resistance to ciproﬂ  oxacin, TMP/
SMX, and gentamicin present among 50 (61%) of 82 iso-
lates and a four-drug resistance to ciproﬂ  oxacin, TMP/SMX, 
gentamicin, and cefazolin present among 37 (45%) isolates. 
The most common coresistance pattern among   E coli   iso-
lates was also ciproﬂ  oxacin, TMP/SMX, and gentamicin 
present among 30 (64%) of 47 isolates. Among   P. stuartii  
isolates, the most common MDR pattern was four-drug re-
sistance to extended-spectrum penicillins, ciproﬂ  oxacin, 
gentamicin, and cefazolin present among 9 (47%) of 19 iso-
lates, and three-drug resistance to extended-spectrum peni-
cillins, cefazolin, and ciproﬂ  oxacin present among 8 (42%) 
isolates.            
 Discussion 
  Although VRE and MRSA have been the antimicrobial-
resistant bacteria of greatest concern in the LTCF, this study 
underscores the emerging threat of MDRGN in this patient 
population. Throughout the 2-year study period, the preva-
lence of MDRGN surpassed that of MRSA and VRE. Of 
further concern was the documentation of a steady rise in 
MDRGN isolates throughout the study period, increasing 
from 7% in 2003 to 13% in 2005. More than 80% of 
MDRGN isolates were resistant to commonly prescribed 
antimicrobials, including ciproﬂ  oxacin,  TMP/SMX,  and 
ampicillin/sulbactam. Antimicrobial resistance to broader 
spectrum antimicrobials, although less frequent, was still 
notable with 14% and 5% of MDRGN isolates resistant to 
ceftriaxone and piperacillin/tazobactam, respectively. The 
majority of MDRGN isolates were resistant to three differ-
ent antimicrobial groups; however, more than one third 
were resistant to four or more different antimicrobial groups. 
These ﬁ  ndings raise serious concern about the therapeutic 
options available to physicians in treating LTCF residents 
with MDRGN infections. Furthermore, they imply that cur-
rent infection control efforts focusing on preventing the 
ongoing rise in VRE and MRSA may need reevaluation to 
include MDRGN (  11  ). Previous point prevalence studies 
focusing on the LTCF population have also documented 
similar rates of multidrug resistance among gram-negative 
bacteria (  12  ). Risk factors for harboring MDRGN among 
this patient population include pressure ulcers, poor func-
tional status, advanced dementia, and antimicrobial expo-
sure  ( 12  –  17 ).  A  large  prospective  study  focusing  on 
antimicrobial exposure among residents with advanced 
dementia documented extensive antimicrobial use in this 
patient population, with 42% of residents in LTCF receiving 
antimicrobials within 2 weeks prior to death (  13  ). 
  The majority of MDRGN isolates were recovered from 
urine specimens and therefore may have represented coloni-
zation as opposed to true infection. Although this ﬁ  nding 
could imply that there may not be substantial morbidity or 
mortality associated with the high prevalence of MDRGN in 
this study, it is important to note that several studies have 
shown that colonization precedes infection and that 15%  –
  25% of patients colonized with MDRGN will subsequently 
develop an infection with the identical MDRGN colonizing 
strain (  18  ,  19  ). Future studies will need to speciﬁ  cally address 
the outcome of LTCF residents harboring MDRGN. 
 There are several limitations in this study. First, only patho-
gens recovered from clinical cultures were included in the 
analysis, and therefore, residents with asymptomatic coloni-
zation may not have been captured. Thus, the prevalence of 
MDR organisms may be an underestimate. Second, this study 
was performed at one large urban LTCF and therefore may 
 Figure  2.         Coresistance  patterns  among  gram-negative  bacteria  recovered  from  clinical  cultures.       EMERGING MDRGN IN LONG-TERM CARE  141
not be generalizable to other LTCF. Although the demograph-
ics of our patient population is comparable with national av-
erages for other LTCF, differences in health care worker 
stafﬁ  ng and compliance with infection control measures, in 
addition to antimicrobial use, may lead to different rates of 
MDRGN in other LTCF (  20  ,  21  ). Third, there is no standard-
ized deﬁ  nition for multidrug resistance among gram-negative 
bacteria (  22  ). Nevertheless, the deﬁ  nition used in this study 
is comparable with previously published deﬁ   nitions  ( 5 , 6 ). 
Lastly, although this study was retrospective in design, the 
use of computerized microbiological and medical records for 
data collection minimized any potential biases or omissions. 
  The novel ﬁ  ndings provided from this study emphasize the 
urgent need for further research on the epidemiology of 
MDRGN in the LTCF setting, including transmission patterns, 
the natural history of MDRGN colonization, rates of infection, 
and associated morbidity and mortality. Hospitals have 
recently begun to include MDRGN in their surveillance of 
antimicrobial-resistant bacteria and many have extended the 
requirement for contact precautions to MDRGN, in addition 
to VRE and MRSA (  23  ). Future research will determine if 
similar changes should be implemented in the LTCF setting.      
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